Cardiac Amyloidosis Registry of University Hospital Leipzig
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This is a clinical registry of patients with cardiac amyloidosis being treated at University Hospital Leipzig. The aim of the registry is to collect detailed information about clinical events, symptoms, imaging, biomarkers, comorbidities, and treatment from routine patient management which would not be provided by randomized clinical trails.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Confirmed cardiac amyloidosis according to current standards
Locations
Other Locations
Germany
University Hospital Leipzig
RECRUITING
Leipzig
Contact Information
Primary
Daniel Lavall, MD
daniel.lavall@medizin.uni-leipzig.de
+493419712650
Backup
Romy Gessner, MD
romy.gessner@medizin.uni-leipzig.de
+493419712650
Time Frame
Start Date: 2023-05-01
Estimated Completion Date: 2033-05
Participants
Target number of participants: 500
Treatments
Cardiac Amyloidosis
Patients with diagnosed cardiac amyloidosis being treated at Leipzig University Hospital.
Related Therapeutic Areas
Sponsors
Leads: University of Leipzig